Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer

Immune dysfunction is one of the hallmarks of cancer and plays critical roles in immunotherapy resistance, but there is no serum biomarker that can be used to evaluate immune-dysfunction status of cancer patients. Here, we identified subtype-specific human endogenous retrovirus K102 envelope (HERV-K...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Qinyuan Gong, Rongzhen Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Subjects:	cancer immunosuppression endogenous retroviruses HML-2 subtype HERV-K102 serum biomarker
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1533740/full